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Chronic obstructive pulmonary disease (COPD) patients suffer from significant impairment in quality of life (QL), 
but the variables related to this impairment are not well known. The aim of this study has been to identify 
physiological parameters related to QL in severe COPD patients undergoing long-term oxygen therapy. 
Materials andmethods. We studied 47 COPD patients using long-term oxygen therapy (43 men/four women, 65.17 
SD 8.21 years, 3.17 SD 2.61 years on oxygen). The Nottingham Health Profile (NHP) and activities of daily living 
(ADL) questionnaire were used to measure QL. Subjective assessment of dyspnoea was performed using a visual 
analogue scale. The physiological parameters determined were lung function (spirometry, arterial blood gases, lung 
volumes and carbon monoxide diffusing capacity), muscle function (maximum inspiratory and expiratory pressures, 
deltoid muscle and handgrip strength), and nutrition status (tricipital skin fold and mid-arm muscle circumference). 
Results. High ADL (8.32 SD 6.97) and NHP scores (energy 63.3 SD 40.43, pain 35.11 SD 31.56, emotional reactions 
43.03 SD 25.13, sleep 51.91 SD 32.75, social isolation 30.64 SD 26.98, physical mobility 49.73 SD 24.93) demonstrated 
clinically significant QL impairment in the severe COPD patients studied. Stepwise multiple regression analysis 
found a correlation between lung function and QL. Low FEV,% was associated with impairment in energy, physical 
mobility and social isolation NHP scores and ADL score (r= - 0.3, PcO.05). RVlTLC also correlated with ADL 
and social isolation scores (r=0.3, PO.05). Lung function explained 3945% of the variation in these QL 
dimensions. QL did not correlate with other lung function parameters, muscle function or nutrition status. 
Conclusion. COPD patients using long-term oxygen suffer from severe QL impairment affecting not only energy 
and mobility but also emotional reactions, social isolation and sleep. Lung function is related to energy, mobility and 
social isolation dimensions, but muscle function is unrelated to QL in these patients. 
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Introduction 
Patients with severe chronic obstructive pulmonary disease 
(COPD) suffer from significant impairment in their quality 
of life (QL) when compared with the general population (1). 
Moreover, QL is much worse in severe COPD patients than 
in light/moderate COPD patients (1,2) and is manifested 
not only as a loss of physical mobility, but also as 
impairment in emotional reactions and sleep (3,4). 
QL determinants in COPD patients, however, are not 
well defined. Lung function is related only to those aspects 
of QL involving mobility and energy (5,6). Dyspnoea 
correlates better with QL because both variables are 
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patient-based and dyspnoea is a main determinant of 
physical mobility (7,8). Finally, the influence of muscle 
function and nutrition status on the QL of COPD patients 
is poorly understood. 
The aim of our study has been to assess QL impairment 
in severe COPD patients using long-term oxygen therapy 
and to investigate the physiological parameters related to 
QL in this population. For such purposes general health 
questionnaires give a description of areas of main impor- 
tance in daily life not directly related to respiratory 
performance (3,4), and this makes them especially useful for 
studies looking at the overall impact of COPD. 
Materials and Methods 
PATIENTS 
All COPD patients using long-term oxygen therapy in 
North Barcelona (657 376 inhabitants) are periodically 
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referred to our university hospital for assessment of their 
clinical status and monitoring of oxygen use (9). All sub- 
jects from this population who had neither used long-term 
corticotherapy nor followed rehabilitation programmes the 
previous year and who were able to answer a QL question- 
naire and perform lung and muscle function tests were 
considered suitable for the present cross-sectional study. A 
total of 47 patients with severe COPD (FEV,/FVC ~50%) 
(lo,1 1) who had been using long-term oxygen therapy over 
the last 3.17 (SD 2.61) yr were enrolled in the study (43 
men/four women; age: 65.17 SD 8.21 years; height: 162.47 SD 
7.99 cm; weight: 68.91 SD 13.51 kg). Arterial blood analysis 
showed chronic respiratory insufficiency (PaO, ~60 mmHg) 
in all cases. 
QUALITY OF LIFE ASSESSMENT 
The Spanish version of the Nottingham Health Profile 
(NHP) was used to measure the QL of this group (12). The 
NHP is a self-administered questionnaire on perceived 
general health that was developed in the United Kingdom 
and contains 38 statements pertaining to six dimensions of 
health (energy, pain, emotional reactions, sleep, social 
isolation, and physical mobility). The respondent answers 
‘yes’ if a statement adequately reflects his/her current per- 
ception, or ‘no’ if otherwise (13). The NHP has proved to 
be valid, reproducible, and sensitive to changes over a wide 
range of diseases, including COPD (14,15). NHP scores 
were calculated as previously reported (1,12). Possible 
scores range from 0 (denoting absence of distress in that 
health dimension) to 100 (maximum distress). 
A second self-administered questionnaire on activities of 
daily living (ADL), modified from the list of daily activities 
(16), was used to determine limitation in performing 11 
ADL: (1) walking; (2) sitting up/down; (3) shaving/making 
up/combing; (4) bathing/taking showers; (5) using the toilet; 
(6) dressing/undressing; (7) eating; (8) climbing/descending 
one flight of stairs; (9) going to the street; (10) cooking own 
food; and (11) shopping at the supermarket. For every 
activity the patient was asked to choose between four 
possible options (no difficulty, slight difficulty, great diffi- 
culty, impossible to do without help) that were coded 0, 1, 
2 and 3 from least to most difficult. The general ADL score 
was obtained by adding all the individual scores. Possible 
scores ranged from 0 (no limitation) to 33 (impossible to do 
any activity without help). 
The questionnaires were self-administered by the patients 
after 15 min of relaxation in a quiet room, in all cases 
before the performance of lung and muscle function tests. 
When the patient found the questionnaire hard to read a 
nurse read each question aloud (23/47 patients 48.9%). In 
no case did the nurse give advice directly or indirectly 
as to how to answer. All the patients completed the 
questionnaires correctly. 
Use of oxygen therapy was inquired about in all cases; 
34147 patients were using compressed oxygen, 10147 were 
using an oxygen concentrator and 3147 were using liquid 
oxygen. Most of the patients used long-term oxygen 
more than 15 h a day (34/47). Co-morbidity due to 
non-respiratory chronic diseases was reported by two 
patients suffering from chronic kidney failure and vascular 
insufficiency. 
LUNG FUNCTION ASSESSMENT 
Lung function measurements were performed with the 
patient in a clinically stable condition (no history of exacer- 
bation the previous month) and following 15 min rest. An 
arterial blood sample was obtained with the patient breath- 
ing room air (Radiometer ABL, Copenhagen). Forced and 
slow spirometry (FEV,, FVC, VC, FEV,IFVC), lung 
volumes (RV, RV/TLC), and carbon monoxide diffusing 
capacity (DtCO, KCO) were assessed by a PFT Horizont 
spirometer (SensorMedics Corp., Jorba Linda, CA, USA). 
Spirometric equipment was calibrated daily and checked 
regularly before each subject was tested, and the American 
Thoracic Society Guidelines for measurements were 
followed (17). From the actual values, we calculated the 
percentage of the reference for the patient’s age, height, and 
weight using Mediterranean population reference values 
(18,19). 
Patients were asked by a nurse to rate their usual level of 
dyspnoea at rest, using a visual analogue scale (VAS) (range 
0 mm = no dyspnoea to 170 mm =maximum dyspnoea) 
(20,21). 
MUSCLE FUNCTION AND NUTRITION 
ASSESSMENT 
Respiratory and peripheral muscle function were measured 
after 15 min rest. Measured respiratory muscle function 
parameters were maximum inspiratory pressure (Prmax) 
and maximum expiratory pressure (Pnmax) (cm H,O) and 
their percentage of Mediterranean population reference 
values (22). PImax and PEmax were measured from RV and 
TLC respectively, using the Black and Hyatt method (23). 
To obtain these values, a pressure transducer with a range 
of O-300 cm H,O (Sibelmed-163) and a rigid-tube mouth- 
piece (diameter 2.5 cm) were used. To overcome the learn- 
ing effect, a minimum of ten manoeuvres were required 
until a variation of less than 5% was achieved (24). The 
manoeuvre was supervised by a trained technician, 
who manually compressed the subject’s lips around the 
cylindrical tube to prevent possible loss of pressure as has 
been previously described (25). 
Peripheral muscle function was measured using the 
strength of the deltoid muscle as previously described 
(left arm for right-handed patients, right arm for left- 
handed ones) (26). For these measurements an electronic 
myometer was used (Peny and Giles Ltd, Christchurch, 
England) (absolute values in kg). Handgrip strength 
of the non-dominant arm was also measured using a 
hand-held dynamometer (Lafayette 32528 HD) (absolute 
values in kg). 
The skin fold of non-dominant triceps and non-dominant 
mid-arm muscle circumference, and their percentile in terms 
of Mediterranean population reference values (27) were 
the nutrition parametes measured. The skin fold was 
measured using a lipocalibrator (Holtain, Cambridge, 
FIG. 1. Nottingham Health Profile dimensions. Results 
obtained in severe COPD patients with chronic 
respiratory insufficiency (means). 
United Kingdom) on the posterior aspect of the triceps, 
midway between the olecranon process of the ulna and the 
acromion process of the scapula, using the standard tech- 
nique (mm) (28). Mid-arm muscle circumference was 
measured using a millimetred tape firmly placed at the 
mid-point of the arm at the same point as the tricipital skin 
fold (cm). 
STATISTICAL ANALYSIS 
All the data were expressed as means and standard devia- 
tions unless specified. Pearson correlation coefficients were 
calculated to determine the relation between physiological 
variables (lung function, muscle function, nutrition), and 
subjective patient-based variables (NHP scores, ADL score, 
VAS). Stepwise regression analyses were performed using 
NHP and ADL scores as dependent variables and lung 
function, muscle function, nutrition status and VAS as 
independent variables. Results were considered statistically 
significant when PcO.05. 
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Results 
QUALITY OF LIFE ASSESSMENT 
The mean score on the ADL questionnaire was 8.32 SD 
6.97, corresponding to clinically significant difficulty in the 
performance of the daily activities assessed. Scores on the 
various dimensions of the NHP were 63.3 (SD 40.3) for 
energy; 35.11 (SD 31.56) for pain; 43.03 (SD 25.13) for emo- 
tional reactions; 51.91 (SD 32.75) for sleep; 30.64 (SD 26.98) 
for social isolation; and 49.73 (SD 24.93) for physical mobil- 
ity (Fig. 1). All these NHP scores reflected severe limitation, 
considering that the mean scores for the general population 
of Spain are under 18 on all dimensions (30). 
LUNG FUNCTION ASSESSMENT 
All patients suffered from severe COPD as determined by 
forced spirometry: FEV, 0.91 1 (SD 0.43); FEV,% 31.79 
(SD 11.97); FVC 1.88 1 (SD 0.60); FVC% 48.02 (SD 13.64); 
FEV,/FVC 48.43 (SD 11.23). Arterial blood analysis 
showed chronic respiratory insufficiency in all cases: 
pH 7.38 (SD 0.04); Pa& 50.25 mmHg (SD 7.71); PaCO, 
52.93 mmHg (SD 9.12); and 0, saturation 82.94% (SD 8.81). 
Results for lung volumes showed high residual volumes: 
RV 3.87 1 (SD 1.28); RV% 187.76 (SD 61.48); RV/TLC 63.04 
(SD 9.19). Observed carbon monoxide diffusing capacities 
were low (DLCO% 66.38 SD 30.02), but were within the 
reference range when adjusted (KCO% 90.76 ~~38.64). Nine 
patients could not perform lung volume tests and/or TLC0 
manoeuvres correctly, and their results were therefore not 
considered. 
MUSCLE FUNCTION AND NUTRITION 
ASSESSMENT 
In most cases, Prmax, Pnmax, skin fold of non-dominant 
triceps and non-dominant mid-arm muscle circumference 
were within the normal range (Table 1). Only in 2/47 cases 
(one skin fold and one mid-arm muscle circumference) were 
TABLE 1. Muscle function and nutrition status 
Min Max Mean SD 
Ptmax (cm H,O) 29.00 117.00 60.45 22.83 
Prmax% 34.00 163.00 82.53 30.38 
PEmax (cm H,O) 40.00 256.00 150.47 51.41 
Pnmax% 34.00 220.00 124.26 40.82 
DS (kg) 6.00 24.80 14.10 3.71 
HS (kg) 0.00 34.00 11.99 8.21 
TSF (mm) 0.77 30.16 15.77 8.38 
TSF percentile 1.00 99.00 69.28 37.34 
MC (cm) 21.00 39.15 29.35 4.02 
MC percentile 1 .oo 99.00 66.83 34.43 
Prmax=maximum inspiratory pressure; pEmax=maximum expiratory pressure; DS=deltoid 
strength; HS = handgrip strength; TSF = tricipital skin fold; MC =mid-arm circumference. 
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TABLE 2. Relationship (Pearson correlation coefficients) between lung function and quality of life 
VAS ADL E P ER S SI PM 
FEV, 0.15 - 0.30 - 0.22 - 0.01 0.07 - 0.13 - 0.18 - 0.27 
n.s. * ns. ns. n.s. n.s. n.s. n.s. 
FEV,% 0.14 - 0.33 - 0.32 0.00 - 0.06 - 0.20 - 0.30 - 0.34 
n.s. * * n.s. n.s. n.s. * * 
FEVJFVC 0.02 - 0.29 - 0.20 - 0.07 - 0.05 - 0.30 - 0.18 - 0.24 
n.s. ns. n.s. n.s. n.s. * n.s. n.s. 
RV/TLC - 0.05 0.33 0.14 0.09 0.00 0.11 0.34 0.24 
ns. * n.s. n.s. n.s. ns. * ns. 
KCO% 0.07 - 0.22 - 0.26 - 0.08 - 0.08 - 0.19 - 0.33 - 0.24 
ns. n.s. ns. n.s. n.s. n.s. * ns. 
VAS=visual analogue scale; ADL=activities daily living; Nottingham Health Profile: E=energy; 
P= pain; ER =emotional reactions; S = sleep; SI = social isolation; PM = physical mobility. 
*p<o.o5. 
ns. =not significant. 
the results obtained below the 5th percentile, showing 
malnutrition. 
CORRELATION BETWEEN PHYSIOLOGICAL 
PARAMETERS AND QUALITY OF LIFE 
Correlation between the various lung function parameters 
and QL scores are shown in Table 2. No significant 
correlations were found between QL scores and device used 
for long-term oxygen therapy (compressed oxygen, concen- 
trator, liquid oxygen) or h day- ’ of use (> 15 h or < 15 h). 
Significant correlations (PcO.05) were found between years 
since initiating oxygen therapy and VAS, ADL scores and 
results on the NHP physical mobility dimension (rz0.3, 
Pearson correlation coefficient), suggesting that longer use 
of oxygen was associated with more dyspnoea, higher 
limitation in daily activities and mobility impairment. We 
found no significant correlation between arterial blood 
gases and VAS, ADL score or any of the NHP dimensions. 
Lung function parameters (FEV,, RV/TLC) and QL 
were also significantly correlated. Low FEV,% was associ- 
ated with limitation in daily activities and high scores on 
the energy, physical mobility and social isolation NHP 
dimensions (Y= - 0.3, Pearson correlation coefficient). High 
RVlTLC was also related to limitation in daily activities 
and a high social isolation score (r=O.3, Pearson correlation 
coefficient). No significant correlation was found between 
any other lung function parameter (FVC%, VC%, RV%, 
arterial blood gases) and QL. Carbon monoxide transfer- 
ence was unrelated to QL, except for a slight correlation 
between KC0 and the social isolation score (r= - 0.3, 
Pearson correlation coefficient) (Table 2). No significant 
correlation was found between QL and muscle function 
parameters (Prmax, Pnmax, PImax%, Pnmax%, deltoid and 
handgrip strength) or nutritional status (tricipital skin fold 
and mid-arm circumference). 
Lung function parameters were not significantly corre- 
lated with dyspnoea (VAS), but dyspnoea, a subjective 
parameter, correlated significantly with QL. VAS score was 
related to ADL score and to scores on most NHP dimen- 
sions (energy, pain, emotional reactions and physical 
mobility; r= 0.34 to 0.5 1, Pearson correlation coefficient). 
Stepwise multiple regression analysis revealed that lung 
function explains 3945% (model R2) of the variance 
for some dependent variables (energy, physical mobility, 
social isolation). The amount of explained variance 
increased when dyspnoea (VAS) was also considered 
as an independent variable, but only slightly (model R2: 
45-69%). 
Discussion 
COPD patients using long-term oxygen suffer from severe 
QL impairment. Our COPD patients scored higher than 30 
on all NHP dimensions, well above the general populations 
of Barcelona and Nottingham (13,29). The level of distress 
was especially high for energy (63.8), physical mobility 
(49.9), emotional reactions (35.1) and social isolation (30.6) 
and all these scores were much higher than those found in 
COPD patients with less severe disease (1,30). The 
high degree of distress found in this group of severe 
COPD patients cannot be explained by co-morbidity (31) 
because only 4.4% suffered from an associated chronic 
non-respiratory disease. 
Our observations agree with previous studies pointing to 
a marked deterioration in general health in patients with 
severe COPD (4,8,32,33). Chronic respiratory disease, like 
arthritis, gastrointestinal disorders and angina, is one of the 
chronic diseases that have a negative impact on all dimen- 
sions of a patient’s general sense of well-being (31,3436), 
but the main determinants of QL impairment in COPD 
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patients are not fully understood. The aim of our study was 
to determine which physiological variables are associated 
with QL in severe COPD patients on long-term oxygen, and 
we found significant correlations between lung function 
(FEV,%, RVITLC) and QL in this group. Lower FEV,% is 
associated with the perception of energy loss, impairment 
in physical mobility and higher limitation in daily life 
activities, and a similar degree of correlation was found 
between QL dimensions and RV/TLC. Interestingly, lung 
function impairment was associated with the perception of 
social isolation in this group of severe COPD patients, an 
impact not previously recognized in COPD patients with 
less severe disease. This effect of COPD on the sociability 
of the patient may be related to the severity of disease 
or to the restriction in mobility associated with long-term 
oxygen use. 
Overall, the results of our multiple regression analysis 
confirmed that lung function explains almost 50% of QL 
variation. It is generally recognized that the score obtained 
on general health questionnaires partially depends on non- 
physiological patient-based variables, which includes psy- 
chological and sociological characteristics of the subject 
(37-39). Dyspnoea is a subjective parameter that, in our 
study, did not correlate significantly with lung function, but 
was related to QL (r=0.34 to 0.51) and contributed an 
additional 624% toward explaining the QL variation in the 
studied sample. 
Lung function and dyspnoea, then, are different factors 
that characterize the condition of patients with COPD (40) 
and muscular performance is a third factor independently 
related to the pathophysiological condition of these patients 
(41). Exercise tests, respiratory pressures and peripheral 
muscle strength can be used to assess muscle performance, 
and in our study we selected Prmax, PEmax and peripheral 
muscle force for such assessment, after considering the 
strong correlation between either peripheral muscle 
strength or PImax and exercise capacity in COPD patients 
(42,43). We failed, however, to find a correlation between 
QL and peripheral muscle force or respiratory pressures. In 
COPD patients, Mahler et al. found a low but statistically 
significant correlation (r=O.3) between Prmax and general 
health status (44) but their patients had light-to-moderate 
obstructive disease. The differences between Mahler’s find- 
ings and ours are probably attributable to greater severity 
of disease in our COPD patients, suggesting that PImax is a 
QL determinant only in COPD patients with light/moderate 
disease. 
We did not find any significant correlation between 
nutritional status and QL. Our COPD patients showed low 
prevalence of severe malnutrition (only 4.2% of the patients 
were in the lowest 5th percentile) and this acceptable 
nutritional status was probably responsible for the observed 
absence of correlation (45,46). 
We did not use respiratory disease-specific question- 
naires, which have proven useful for the study of COPD 
patients (4749) as valid and reliable Spanish versions of 
the Chronic Respiratory Disease Questionnaire and the 
St George’s Respiratory Questionnaire were not available 
when the study was performed (50,51). The NHP, however, 
has been used with COPD patients and has shown its 
accuracy in recognizing the impact of airways disease on 
general health (1). By using the NHP we obtained infor- 
mation on different aspects of daily life and a broad picture 
of QL changes in severe COPD, including aspects such as 
sociability and sleep quality. 
We conclude that COPD patients using long-term oxygen 
suffer from a marked decrease in QL, and that this QL 
impairment affects not only physical dimensions, but also 
emotional reactions, social isolation and sleep. In these 
patients lung function explains almost 50% of the varia- 
bility found in some QL dimensions (energy, physical 
mobility, social isolation), but muscle function has no 
impact on QL, indicating that QL is not strength-dependent 
in COPD patients using long-term oxygen. 
Acknowledgements 
We wish to thank Isabel And&, Trinitat Torrents and 
Virginia Parcel, who performed the quality of life assess- 
ment of the patients; Roser Gomez, who recorded most of 
the physiological measurements; Maria Teresa Art& who 
performed the statistical analysis; and Josep Maria Anto, 
who gave us a critical review of the manuscript. This work 
was funded by FISss 93/0105. 
References 
1. Alonso J, Ant6 JM, Gonzalez M, Fiz JA, Izquierdo J, 
Morera J. Measurement of general health status of 
non-oxygen-dependent chronic obstructive pulmonary 
disease patients. Med Cure 1992; 30: MS125-MS135. 
2. Dardes N, Chiappinni MG, Moscatelli B et al. Quality 
of life of COPD patients treated by long-term oxygen. 
Lung 1990 (Suppl.): 789-793. 
3. Randall Curtis J, Deyo RA, Hudson LD. Health- 
related quality of life among patients with chronic 
obstructive pulmonary disease. Thorax 1994; 49: 162- 
170. 
4. Jones PQ. Quality of life measurement for patients with 
diseases of the airways. Thorax 1991; 46: 676-682. 
5. McSweeny AJ, Grant I, Heaton RK, Adams KM, 
Timms RM. Life quality of patients with chronic 
obstructive pulmonary disease. Arch Intern Med 1982; 
142: 473478. 
6. Prigatano GP, Wright EC, Levin D. Quality of life and 
its predictors in patients with mild hypoxemia and 
chronic obstructive pulmonary disease. Arch Intern 
Med 1984; 144: 1613-1619. 
7. Schrier AC, Dekker FW, Kaptein AA, Dijkman JH. 
Quality of life in elderly patients with chronic non- 
specific lung disease seen in family practice. Chest 1990; 
98: 894899. 
8. Jones PW, Baveystock CM, Littlejohns P. Relation- 
ships between general health measured with the Sick- 
ness Impact Profile and respiratory symptoms, 
physiological measures and mood in patients with 
chronic airflow limitation. Am Rev Respir Dis 1989; 
140: 1538-1543. 
226 E. MONSC~ ETAL 
9. Monso E, Izquierdo J, Pique JL, Co11 R, Mire I, 
Morera J. Chronic home oxygen therapy and other 
pneumological tools in the suburbs and coastal plain 
north of Barcelona. A descriptive study. Arch Bronco- 
neumol 1994; 30: 245-247. 
10. American Thoracic Society statement. Standards for 
the diagnosis and care of patients with chronic obstruc- 
tive pulmonary disease (COPD) and asthma. Am Rev 
Respir Dis 1987; 136: 2255241. 
11. Grupo de Trabajo de la SEPAR. Normativa para la 
espirometria forzada. Doyma SA, Barcelona, 1985. 
12. Alonso J, Ant6 JM, Moreno C. Spanish version of 
the Nottingham Health Profile: translation and 
preliminary validity. Am J Public Health 1990; 80: 
704-708. 
13. Hunt S, McEwen J, McKenna S. Measuring Health 
Status. London: Croom Helm, 1986. 
14. Hunt SM, McKenna SP, McEwen J, Backett EM, 
Williams J, Papp E. A quantitative approach to per- 
ceived health status: a validation study. J Epidemiol 
Community Health 1980; 34: 281-000. 
15. van Schayck CP, Dompelling E, Rutten MP, Folgering 
H, van den Boom G, van Wee1 C. The influence of an 
inhaled steroid on quality of life in patients with 
asthma or COPD. Chest 1995; 107: 1199-1205. 
16. Steward AL, Ware JE, Brook RH. Advances in the 
measurement of functional status: construction of 
aggregate indexes. Med Care 1981; 19: 473488. 
17. Anon. Standardization of spirometry 1987 update. Am 
Rev Respir Dis 1987; 136: 1285-1298. 
18. Rota J, Sanchis J, Agusti-Vidal A et al. Spirometric 
reference values from a Mediterranean population. Bull 
Eur Physiopathol Respir 1986; 22: 217-224. 
19. Rota J, Segarra F, Rodriguez R et al. Static lung 
volumes and single breath diffusing capacity reference 
values from a Latin population. Am Rev Respir Dis 
1985; 131: A352. 
20. Mahler DA. Dyspnea: diagnosis and management. 
Clinics Chest Med 1987; 8: 215-230. 
21. Muza SR, Silverman MT, Gilmore GC, Hellerstein 
HK, Kelsen SG. Comparison of scales used to quanti- 
tate the sense of effort to breathe in patients with 
chronic obstructive pulmonary disease. Am Rev Respir 
Dis 1990; 141: 909-913. 
22. Fiz J, Haro M. Physiopathology of COPD patient. In: 
Morera J, Picado C, eds. Chronic Obstructive Pulmon- 
ary Disease, Vol 1. Barcelona: Proformaco SA, 1993, 
pp. 27-52. 
23. Black LF, Hyatt RE. Maximal inspiratory pressures: 
normal values and relationship to age and sex. Am Rev 
Respir Dis 1969; 99: 696702. 
24. Fiz JA, Montserrat JM, Picado C, Plaza V, Agusti- 
Vidal A. How many manoeuvres should be done to 
measure maximal inspiratory mouth pressure in 
patients with chronic airllow obstruction? Thorax 1989; 
44: 419421. 
25. Fiz JA, Haro M, Aguilar J, Alvarez J, Abad J, Monso 
‘, E, ,Morera, J. Spirometry and maximal respiratory 
jf- pressures in patients with facial paralysis. Chest 1993; 
103: 170-173. 
26. Picado C, Fiz JA, Montserrat JM et al. Respiratory 
and skeletal muscle function in steroid-dependent 
bronchial asthma. Am Rev Respir Dis 1990; 141: 14-20. 
27. Ricart W, Gonzalez-Huix F, Conde V. The evaluation 
of the state of nutrition through the determination of 
anthropometric parameters: new tables in the working 
population in Catalonia (Spain). Med Cfin (Bare) 1993; 
100: 681-691. 
28. Jelliffe DB. The assessment of nutritional status of the 
community. Ginebra: WHO Monographs Series, 1966, 
num 53. 
29. Alonso J, Ant6 JM. Enquesta de Salut de Barcelona 
1986. Ajuntament de Barcelona, Barcelona: 1989, p. 65. 
30. Van Schayck CP, Rutten-van Molken MPM, van 
Doorslaer EKA, Folgering H, van Wee1 C. Two-year 
bronchodilator treatment in patients with mild airflow 
obstruction. Contradictory effects on lung function and 
quality of life. Chest 1992; 102: 13841391. 
31. Steward AL, Greenfield S, Hays RD et al. Functional 
Status and well-being of patients with chronic con- 
ditions. JAMA 1989; 262: 907-913. 
32. Nocturnal Oxygen Therapy Trial (NOTT) Group. 
Continuous or nocturnal oxygen therapy in hypoxemic 
chronic obstructive lung disease. Ann Intern Med 1980; 
133: l&20. 
33. Intermittent Positive Pressure Trial Group. Intermit- 
tent positive pressure breathing therapy of chronic 
obstructive pulmonary disease. Ann Intern Med 1983; 
99: 612-620. 
34. Kaplan RM, Atkins CJ, Timms R. Validity of a 
well-being scale as an outcome measure in chronic 
obstructive pulmonary disease. J Chron Dis 1984; 37: 
85-95. 
35. Williams SJ, Bury MR. Impairment, disability and 
handicap in chronic respiratory illness. Sot Sci Med 
1989; 29: 609-616. 
36. Jones P, Quirk FH, Baveystock CM, Littlejohns P. 
A self-complete measure of health status for chronic 
airflow limitation. The St George’s Respiratory Ques- 
tionnaire. Am Rev Respir Dis 1992; 145: 1321-1327. 
37. Prigatano, King B, Cotes JE. Relation of lung function 
and exercise capacity to mood and attitudes to health. 
Thorax 1989; 44: 402409. 
38. Kaptein AA. Psychological correlates of length of 
hospitalization and rehospitalisation in patients with 
acute, severe asthma. Sot Sci Med 1982; 16: 725-729. 
39. Williams SJ. Chronic respiratory illness and disability: 
a critical review of the psychosocial literature. Sot Sci 
Med 1989; 28: 791-803. 
40. Wegner RE, Jorres RA, Kirsten DK, Magnussen H. 
Factor analysis of exercise capacity, dyspnoea ratings 
and lung function in patients with severe COPD. Eur 
Respir J 1994; 7: 725-729. 
41. Mahler DA, Harver A. A factor analysis of dyspnea 
ratings, respiratory muscle strength, and lung function 
in patients with chronic obstructive pulmonary disease. 
Am Rev Respir Dis 1992; 145: 467470. 
42. Gosselink R, Troosters T, Decramer M. Peripheral 
muscle weakness contributes to exercise limitation in 
COPD. Am J Respir Crit Care Med 1996; 153: 976-980. 
SEVERE CHRONIC OBSTRUCTIVE PULMONARYDISEASE 227 
43. Wilkstra PJ, TenVergert EM, van der Mark Th W et al. 
Relation of lung function, maximal inspiratory pres- 
sure, dyspnoea, and quality of life with exercise capac- 
ity in patients with chronic obstructive pulmonary 
disease. Thorax 1994; 49: 468472. 
44. Mahler DA, Faryniarz, Tomlinson D et al. Impact of 
dyspnea and physiologic function on general health 
status in patients with chronic obstructive pulmonary 
disease. Chest 1992; 102: 395401. 
45. Kelly SM, Rosa A, Field S, Coughlin M, Shizgal HM, 
Macklem PT. Inspiratory muscle strength and body 
composition in patients receiving total parenteral 
nutrition therapy. Am Rev Respir Dis 1984; 130: 
33-37. 
46. Laaaban JP, Kouchakji B, Dore MF, Orvoen-Frija E, 
David P, Rochemaure J. Nutritional status of patients 
with chronic obstructive pulmonary disease and acute 
respiratory failure. Chest 1993; 103: 1362-1368. 
47. Jones PW, Quirk FH, Baveystock CM. The St George’s 
Respiratory Questionnaire. Respir Med 1991; 85 
(Suppl. B): 25-3 1. 
48. Guyatt GH, Towsend M, Keller J, Singer J, Nogradi S. 
Measuring functional status in chronic lung disease: 
conclusions from a randomized control trial. Respir 
Med 1991; 85 (Suppl. B): 17-21. 
49. Okubadejo AA, Jones PW, Wedzicha JA. Quality of 
life in patients with chronic obstructive pulmonary dis- 
ease and severe phypoxaemia. Thorax 1996; 51: 4447. 
50. Guell R, Casan P, Sangenis M et al. The Spanish 
translation and evaluation of a quality of life question- 
naire in patients with chronic obstructive pulmonary 
disease. Arch Bronconeumol (Bare) 1995; 31: 202-210. 
51. Ferrer M, Alonso J, Prieto L et al. Validity and 
reliability of the St George’s Respiratory Questionnaire 
after adaptation to a different language and culture: the 
Spanish example. Eur Respir J 1996; 9: 1160-l 166. 
